We are the first to report the favorable clinical efficacy and safety of ICIs plus SBRT combined with chemotherapy in first-line mPC. And ICSBRT presented promising efficacy, and this supported ongoing this combination as the first-line treatment in patients with mPDAC. 【Reference】 [1] Bray ...
the Company intends to distribute substantially all the net revenue arising from the portfolio and is expected to pay an annual dividend, but this may vary substantially from year to year.
Could we rely on the mainstream media to even report it? This is the same media that, after Trump was clearly shot on live television, reported “Trump escorted away after loud noises at PA rally.” (Washington Post). And “Secret Service rushes Trump offstage after he falls at rally.”...